Francesca Aroldi, discusses the early efficacy data with RP2 in advanced solid tumors.
Francesca Aroldi
Advertisement
Articles by Francesca Aroldi
Advertisement
Latest Updated Articles
Early Efficacy Data With RP2 in Advanced Solid TumorsPublished: November 13th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
The OncFive: Top Oncology Articles for the Week of 1/25
2
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5